This report outlines how to move from passive spend tracking to proactive operational control. Key takeaways include:
- The seven essential metrics: The exact data points every DSO leadership team needs to track across practices, clinicians, and SKUs.
- Targeted action plans: How to address high remake rates, uneven lab spend, or limited efficiency gains.
- Quality control at scale: How deploying AI Scan Review and analysing prep quality standardises outcomes across locations.
- Revenue drivers: How to shift your organisation’s focus from policing spend to scaling high-performing clinical behaviours.
- Valuation signals for acquirers: How proving operational control and technical consistency increases EBITDA multiples.
